Tag: Clinical trials
New FDA-Approved Drug for Autoimmune Liver Disease: A Breakthrough Treatment
A breakthrough treatment for autoimmune liver disease has been approved by the U.S. Food and Drug Administration (FDA). The medication, Iqirvo (elafibranor), developed by French drugmaker Ipsen, is a new 80 mg tablet that...
Revolutionizing Drug Development: The Impact of Artificial Intelligence
In a state-of-the-art laboratory at Terray Therapeutics in Monrovia, California, a groundbreaking revolution in drug development is taking place. The lab is a hub of cutting-edge technology and innovation, where robots work tirelessly to...
New Title: FDA Advisory Panel Approves Experimental Alzheimer’s Drug: Promising Progress Ahead
An experimental Alzheimer’s drug called donanemab received approval from a U.S. Food and Drug Administration advisory panel. The drug is intended to treat early symptoms of Alzheimer’s disease, such as mild cognitive impairment and...
FDA Panel Rejects MDMA-Assisted Therapies for PTSD Despite Veteran Support
Recently, a U.S. Food and Drug Administration (FDA) panel made a decision on MDMA-based treatments for post-traumatic stress disorder (PTSD), a treatment often used in veteran care. The advisory committee voted 10-1 against the...
Expert Panel Backs FDA Approval of New Alzheimer’s Drug
An expert panel recently gave its support for the FDA approval of a new drug for Alzheimer's disease called donanemab, manufactured by Eli Lilly. The panel, made up of independent advisors to the FDA,...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says COVID-flu combo vaccine...
A combination vaccine for COVID and influenza is showing promising results in phase 3 trials conducted by Moderna. The experimental vaccine, mRNA-1083, has demonstrated a better immune response compared to other vaccines currently available....
Experimental Alzheimer’s drug receives FDA advisory panel’s approval: Progress is happeningSEO-friendly title: Alzheimer’s Drug...
An experimental Alzheimer's drug called donanemab received an endorsement from a U.S. Food and Drug Administration (FDA) advisory panel. The drug is intended to target symptoms of early Alzheimer's disease, such as mild cognitive...
Expert Panel Endorses FDA Approval of New Alzheimer’s Drug New Alzheimer’s Drug Receives Expert Panel...
An expert panel has given their endorsement to the FDA approval of a new drug for Alzheimer's disease. The drug, called donanemab and manufactured by Eli Lilly, was found to have modest benefits that...
FDA panel rejects MDMA-assisted therapies for PTSD veterans’ hopes dashed.New Title: FDA Panel...
The recent decision by a U.S. Food and Drug Administration (FDA) panel to reject MDMA-based treatments for post-traumatic stress disorder (PTSD) has left many veterans disappointed. The advisory committee voted 10-1 against the overall...
More Progress With Less Intensive Treatment, Crucial New Research For People Battling Cancers Like...
New Breakthroughs in Cancer Treatment: Less Intensive Therapy Shows Promise for Ovarian, Esophageal, and Hodgkin Lymphoma PatientsNew research presented at the 2024 American Society of Clinical Oncology (ASCO) annual meeting has shed light on...
Is Semaglutide the ‘New Statin’? Not So Fast
Is Semaglutide the Breakthrough Treatment for Obesity and Cardiovascular Disease?
There has been much excitement surrounding the results of the SELECT cardiovascular outcomes trial (CVOT) presented at this year's European Congress on Obesity, with many...
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract CancerThe National Medical Products Administration (NMPA) in China has approved the biologics license application (BLA) for zanidatamab for the treatment of patients with HER2-positive...
Scientists find new method to enhance efficacy of bispecific antibodies for solid tumors
Breakthrough Study Reveals Innovative Approach to Boost Effectiveness of Bispecific Antibodies in Solid Tumor TreatmentA recent study has unveiled a groundbreaking method to enhance the efficacy of bispecific antibody therapies for solid tumors. The...
Ovarian Cancer Drugs Market to Reach USD 9,857 Million by 2032 | Market.us
Ovarian Cancer Drugs Market Projected to Reach USD 9,857 Million by 2032In recent market analysis, the Global Ovarian Cancer Drugs Market is expected to reach a value of USD 9,857 million by the year...
Protein Discovery Advances Metabolic Disease Treatment
Protein Discovery Revolutionizes Metabolic Disease Treatment StrategiesA groundbreaking discovery by a University of Saskatchewan (USask) research team has unveiled the remarkable health benefits of a protein that suppresses appetite, opening up new possibilities for...
This New Blood Test Could Help Solve The Mystery of Multiple Sclerosis
New Blood Test Unveiled to Understand Multiple Sclerosis CausesA groundbreaking blood test has been developed to estimate the strength of the immune response in individuals with multiple sclerosis (MS). With an estimated 2.8 million...